Data / Drug companies / Meropenem
Meropenem: 17 companies and 47 products in the FDA NDC directory
Meropenem is listed in the FDA National Drug Code Directory by 17 companies, with 47 products in commercial distribution. 46 of the products (97.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, for solution; injection, and the newest product started marketing on August 25, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 47
- Generic (ANDA) products
- 46 (97.9%)
- Application numbers
- 10
- Routes
- Intravenous
- openFDA record search
- api.fda.gov
Companies that list meropenem
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 6 | injection, powder, for solution | Generic drugs (ANDA) | October 26, 2011 |
| WG Critical Care, LLC | 5 | injection, powder, for solution | Generic drugs (ANDA) | September 8, 2023 |
| Civica, Inc. | 4 | injection | Generic drugs (ANDA) | September 8, 2025 |
| Hikma Pharmaceuticals USA Inc. | 4 | injection; injection, powder, for solution | Generic drugs (ANDA) | August 25, 2026 |
| Hospira, Inc. | 4 | injection, powder, for solution | Generic drugs (ANDA) | December 6, 2022 |
| Brooks Steriscience Limited | 3 | injection | Generic drugs (ANDA) | June 27, 2025 |
| Amneal Pharmaceuticals LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | May 9, 2016 |
| Armas Pharmaceuticals Inc. | 2 | injection | Generic drugs (ANDA) | August 10, 2023 |
| BluePoint Laboratories | 2 | injection, powder, for solution | Generic drugs (ANDA) | April 30, 2017 |
| Eugia US LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | March 27, 2017 |
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | April 28, 2017 |
| Qilu Antibiotics Pharmaceutical Co., Ltd. | 2 | injection | Generic drugs (ANDA) | December 30, 2024 |
| Sagent Pharmaceuticals | 2 | injection, powder, for solution | Generic drugs (ANDA) | November 1, 2025 |
| Sandoz Inc | 2 | injection | Generic drugs (ANDA) | August 29, 2016 |
| Savior Lifetec Corporation | 2 | injection | Generic drugs (ANDA) | April 19, 2016 |
| Xellia Pharmaceuticals USA LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | June 28, 2021 |
| Mylan Institutional LLC | 1 | injection | Generic drugs (ANDA) | July 1, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, for solution | 27 | 57.4% |
| Injection | 20 | 42.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 46 | 97.9% |
| New drug applications (NDA) | 1 | 2.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Penem Antibacterial | 47 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.